Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Peer-led Group Intervention for Coping With Disaster

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03907995
Recruitment Status : Not yet recruiting
First Posted : April 9, 2019
Last Update Posted : May 14, 2019
Sponsor:
Collaborator:
American National Red Cross
Information provided by (Responsible Party):
Eric Alan Storch, Baylor College of Medicine

Brief Summary:
The present project partners with leading faith communities in Houston to provide expert-led educational workshops to a diverse sample of adults on normative and concerning response to disaster. Secondly implementing peer-led interventions where a trained adult leads others through an evidence-based manualized intervention. Lastly, identifying and referring individuals who require more intensive services to a higher level of care.

Condition or disease Intervention/treatment Phase
Anxiety Disorder PTSD Depressive Symptoms Anger Depressive Disorder Behavioral: Cognitive Behavioral Therapy Not Applicable

Detailed Description:
Approximately 20% of individuals have significant behavioral health concerns. Exposure to a disaster like Hurricane Harvey and its aftermath often exacerbates pre-existing issues and/or brings new issues, with post-traumatic stress presenting in manners such as anxiety, depression, conduct issues and/or somatic issues. Approaches are needed that educate community members about both normative and concerning responses to disaster focused on coping skills development. A particular approach, peer-led intervention groups have been shown effective at delivering these types of intervention. Brief, psycho-educational peer-led programs have shown effectiveness in a variety of forums including helping promote adjustment among those who have experienced trauma. There will be six group sessions every two weeks. Sessions will include how to teach appropriate coping techniques to respond to the distress, confronting distressing memories related to the disaster, and emotion regulation techniques. After the group sessions end, individuals who require a more intensive service will be referred to a higher level of care.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Peer-led Group Intervention for Coping With Disaster
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : December 3, 2019
Estimated Study Completion Date : December 3, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Cognitive Behavioral Therapy
The form of treatment will involve 6 group sessions every two weeks about an hour each. Sessions consist of teaching a different coping technique in each session to help cope with disaster or other events.
Behavioral: Cognitive Behavioral Therapy
The form of treatment will involve 6 group sessions every two weeks about an hour each. Sessions consist of teaching a different coping technique in each session to help cope with disaster or other events.
Other Names:
  • Skills for Psychological Recovery
  • CBT




Primary Outcome Measures :
  1. PTSD Symptom Scale - Adult [ Time Frame: Post-treatment, which is 12 weeks after baseline. ]
    The PTSD Symptom Scale - Self Report is a 17-item, Likert-scale, self-report questionnaire designed to assess the symptoms of PTSD according to DSM-IV. Each of the 17 items is rated on a scale from 0 to 3, with total score ranging from 0 to 51 by adding them up.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years and older and English speaking.

Exclusion Criteria:

  • Individuals under the age of 18 and non-English speaking and participants who do not wish to participate in this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03907995


Contacts
Layout table for location contacts
Contact: Eric A Storch, Ph.D 7137984857 copingwithdisaster@bcm.edu

Locations
Layout table for location information
United States, Texas
Baylor College of Medicine: Jamail Specialty Care Center Not yet recruiting
Houston, Texas, United States, 77030
Contact: Richelle Overton         
Principal Investigator: Eric Storch, Ph.D.         
Sub-Investigator: Sophie Scheinder, Ph.D.         
Sub-Investigator: Bella Schanzer, M.D.         
Sponsors and Collaborators
Baylor College of Medicine
American National Red Cross
Investigators
Layout table for investigator information
Principal Investigator: Eric Storch, Ph.D. Baylor College of Medicine

Layout table for additonal information
Responsible Party: Eric Alan Storch, Professor, Baylor College of Medicine
ClinicalTrials.gov Identifier: NCT03907995     History of Changes
Other Study ID Numbers: H-44353
First Posted: April 9, 2019    Key Record Dates
Last Update Posted: May 14, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Depressive Disorder
Depression
Anxiety Disorders
Pathologic Processes
Mood Disorders
Mental Disorders
Behavioral Symptoms